Toward the cancer solution we need: Experts from science, engineering and the humanities join together
Scientists from USC Dornsife and Cedars-Sinai rally scholars around the country and in diverse fields to find better ways of beating the disease.
Largest known genetic study of prostate cancer in men of African descent could improve screening
The USC-led analysis of genetic data fills an urgent research gap for a population that faces a higher risk of prostate cancer than white men.
USC awarded grant to help diverse populations access cancer clinical trials
A two-year grant from Stand Up To Cancer will fund a new program at the USC Norris Comprehensive Cancer Center.
Study shows how liver cancer hijacks circadian clock machinery inside cells
Researchers from the Keck School of Medicine of USC are now one step closer to understanding how to halt the spread of the deadly disease in the body.
USC receives $10.5 million to develop cutting edge machine learning approaches in cancer research
The Research Program Project Grant will enable researchers to develop statistical methods aimed at uncovering new risk factors associated with cancer by drawing upon datasets of several cancer studies.
Unlocking the potential of monoclonal antibodies
Lab-made antibodies are increasingly important in the fight against Alzheimer’s, COVID and other diseases
New drug shows promise for fighting both COVID-19 and cancer
Researchers at the Keck School of Medicine of USC and the Cleveland Clinic Florida have published studies of a protein implicated in both COVID-19 and multiple types of cancer, and a new drug that interferes with its effects.
A different kind of danger challenges USC veteran
Advanced treatment helps a Marine power through a life-threatening disease. Cheering him on are an optimistic oncologist, a close personal advocate and 50,000 fans.
Breakthrough brings potential glioblastoma drug into focus
A new class of small molecule drugs, now in phase 1 clinical trials, is the first to target circadian clock proteins, which play a key role in the recurrence and spread of the deadly cancer.
Next-generation liquid biopsy detects nano-sized signs of breast cancer in early-stage patients
A USC-led team of researchers finds remarkable results with the blood test in a small group of patients.
Decoding the “C” Word
USC researcher John Carpten strives to decode how genes influence cancer — especially for groups hit hardest by the disease
USC, Cancer and One Daring Mission
Powered by an energized cancer-fighting ecosystem at USC, Trojan researchers aim to help the nation achieve its Cancer Moonshot
Finding a Cure
USC researcher Peter Kuhn possesses an unrelenting mission to improve the lives of cancer patients.
Brainstorming new ways to beat breast cancer
USC cancer researcher Min Yu counts on a team that shares her excitement about scientific ideas.
Synthetic ‘forever chemical’ linked to liver cancer
A common manufactured substance may elevate risk of liver cancer, Keck School of Medicine of USC researchers find.
Stress accelerates aging of immune system, study finds
Everyday stressors, traumatic events, job strain and discrimination prematurely weaken the body’s mix of immune cells, potentially increasing a person’s risk of disease.
Research award accelerates USC’s work on next-generation cell therapy for prostate cancer
The California Institute for Regenerative Medicine awards $5.8 million to researchers in the Jane Ann Nohl Division of Hematology at the Keck School of Medicine of USC.
Keck Medicine of USC opens state-of-the-art oncology clinic and infusion center in Newport Beach
The new location uses the latest technology and includes an on-site laboratory and pharmacy to provide patients with coordinated, personalized care.
Metastatic prostate cancer on the rise since decrease in recommended screenings
After routine prostate cancer screenings were no longer recommended, the incidence rate of metastatic prostate cancer rose more than 40% in men 45 and older, a Keck Medicine of USC study found.
2 USC scientists called to serve on Biden’s renewed Cancer Moonshot initiative
John Carpten and Peter Kuhn will serve in the research effort aimed at reducing the national cancer death rate by 50% in the next 25 years.
Cancer Moonshot funds will help USC researchers reduce health disparities in cancer research
The $18.5 million grant will help researchers at USC Norris Comprehensive Cancer Center close the gap in understanding colorectal cancer in Hispanic patients.
Communication between cells plays a major role in deciding their fate
Findings from a new study could point the way to new treatments for blood diseases including cancers such as leukemia and lymphoma.
How alike are the cancer cells from a single patient?
The USC study also underscored a major problem facing cancer researchers: studying non-representative samples of patient cells.
Drug-like molecule points to novel strategies for cancer therapy
Work from scientists led by USC’s Oliver Bell and a colleague could counteract the effects of mutated epigenetic regulators, which are known to drive certain types of cancer including lymphoma.